Financial Modelling Tool for Pharmaceutical Companies
In the pharmaceutical industry, where R&D timelines, regulatory hurdles, and market launches all affect cash flow, having a clear financial roadmap is vital. Brixx gives pharmaceutical companies the tools to model every financial detail, from early-stage development to commercialisation, helping you plan smarter and grow sustainably.
Start for free
Who can use this Brixx template?
Biotech firms
Financial planners in life sciences
Start using this template
Not listed? View all our templates
What are the benefits to pharmaceutical companies?
Pharmaceutical Template
Purpose-built for the pharma sector, this template covers development stages, operational expenses, and revenue milestones
Cash Flow Insights
Simulate cash flows for drug trials, production costs, and sales projections with ease
Visual Reports
Use dynamic charts and reports to communicate pipeline performance to stakeholders
Impact Analysis
Rapidly assess how changes in trial outcomes, licensing deals, or regulatory timelines affect financial stability
Test New Ideas
Instantly see the results of scenario testing for new product launches, manufacturing scale-ups, or funding options
Get started with the best financial projection software – today!
Robust financial modelling isn't just useful – it's essential in pharma, where timelines stretch over years and budgets must adapt to uncertainty. Brixx's financial forecasting software helps you stay ahead, offering insight into every stage of development and enabling you to react quickly to changing conditions.
By forecasting regulatory costs, revenue from future drug sales, and the impact of strategic decisions, you can plan more effectively and increase your company's chances of long-term success. With two decades of business modelling expertise, Brixx equips pharmaceutical businesses with the clarity they need to navigate this complex industry.
Start for freeModel your pharmaceutical business in Brixx – see how quickly your finances can make sense!
Project Setup
- Project Name : Red Pill Pharmaceutical Company
- Time Period : Monthly (suitable for tracking R&D burn rate, revenue milestones, and funding tranches)
Setup 
Income Components
Component: Product Sales
Sub-components:
- Prescription Drug A (e.g. antihypertensive) – £250,000/month
- Prescription Drug B (e.g. oncology treatment) – £400,000/month
- Over-the-counter (OTC) Products – £50,000/month
- International Licensing Revenue – £100,000/quarter
Component: Research Grants & Subsidies
Sub-components:
- Government R&D Tax Credit – £120,000/year
- University/NGO Research Partnerships – £10,000/month
Component: Milestone Payments & Royalties
Sub-components:
- Licensing Agreement with Big Pharma – £500,000 upon successful trial phase
- Ongoing Royalties from Legacy Product – £15,000/month
Income 
Expenditure Components
Component: R&D Costs
Sub-components:
- Clinical Trial Phase II – £150,000/month
- Laboratory Staff Salaries – £100,000/month
- Preclinical Research Supplies – £30,000/month
- Regulatory Filing Costs – £60,000/year
Component: Manufacturing & Distribution
Sub-components:
- Raw Materials – £75,000/month
- Packaging – £10,000/month
- Third-party Manufacturing – £120,000/month
- Distribution & Logistics – £25,000/month
Component: Sales & Marketing
Sub-components:
- Pharmaceutical Sales Reps – £80,000/month
- Digital Advertising Campaigns – £20,000/month
- Trade Shows and Conferences – £60,000/year
Component: Administrative & Overheads
Sub-components:
- Office Rent – £10,000/month
- Insurance & Compliance – £4,000/month
- Accounting & Legal – £3,000/month
- Software Subscriptions – £1,500/month
Expenditure 
Asset Components
Component: Fixed Assets
Sub-components:
- Laboratory Equipment (£500,000, 5-year depreciation)
- Manufacturing Facility (Owned: £2,000,000, appreciating 2% annually)
- Office Equipment (£50,000, 3-year depreciation)
Component: Current Assets
Sub-components:
- Inventory (Finished Goods) – £400,000 average stock
- Cash Reserves – Starting at £1,000,000
- Accounts Receivable – £300,000 (avg. 60-day terms)
Assets 
Funding Components
Component: Equity Investment
Sub-components:
- Series A Investment – £5,000,000 in Year 1
- Series B Investment – £10,000,000 in Year 2
Component: Grants & Subsidies
Sub-components:
- Innovate UK Grant – £500,000 disbursed over 12 months
- Horizon Europe Grant – £1,000,000 disbursed over 18 months
Component: Loans
Sub-components:
- R&D Development Loan – £1,500,000 at 6% over 5 years
Funding 
Scenario Planning in Brixx
R&D Success/Failure
- Model success vs. failure of clinical trials (e.g., success unlocks £500k milestone + future sales, failure halts income + triggers write-off)
Regulatory Approval Delays
- Push launch of Drug B back 6 months and monitor cash runway impact
Drug Price Cuts
- Test 10%, 20%, and 30% reductions in average selling price across major markets
Staff Growth
- Add new R&D and Sales hires over time based on funding rounds
Scenarios 
Dashboard & Reporting
Cash Flow Report
- Monthly burn rate, funding inflows, and sales growth
Balance Sheet
- Growing fixed assets, changing inventory, and liability structure from loans
Profit & Loss Statement
- Revenue breakdown, gross margin, R&D intensity, EBITDA
Custom KPIs
- R&D Spend as % of Revenue
- Burn Rate vs. Cash Reserves
- Time to Breakeven
- Revenue per Product
Dashboard 
Strategic forecasting in Brixx
Projecting the financial impact of successful or delayed clinical trials
Demonstrating future revenue potential for investor pitches or grant applications
Planning for R&D costs, compliance expenses, and manufacturing scale-up
Forecasting capital needs for growth or acquisition opportunities
Evaluating how pricing strategies and global market entry influence revenue streams
Explore different industry frameworks you can build in Brixx for your business
Dental Practice
As a dentist, understanding how your cash flow may fluctuate throughout the year and knowing when to make strategic decisions.
Tech Startup
Running a tech startup means navigating rapid growth, shifting markets, and constant innovation.
Private Healthcare Firm
As a private healthcare business, managing cash flow fluctuations and making strategic financial decisions is crucial.
Manufacturer
Manufacturers and manufacturing business owners must grasp the nuances of cash flow changes throughout the year and the timing of.
Start using Brixx for free
Free for 7 days. No credit card required.
Answer real questions about your business:
- Scenario testing
- 10-year financial forecast
- Pre-built templates
- Xero integration
- Automated reports: P&L, balance sheet, cash flow, tax & more
